Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) fell 4.5% on Tuesday . The company traded as low as $22.99 and last traded at $23.05. 266,559 shares traded hands during trading, a decline of 58% from the average session volume of 630,100 shares. The stock had previously closed at $24.13. Wall Street Analysts Forecast Growth […]
HC Wainwright Reaffirms "Buy" Rating for Cullinan Therapeutics (NASDAQ:CGEM) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Cullinan Oncology (NASDAQ:CGEM – Free Report) had its price target decreased by HC Wainwright from $29.00 to $28.00 in a research report released on Thursday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. Several other equities analysts have also issued reports on CGEM. Jonestrading lifted their price objective on shares of […]
Shares of Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) have been given a consensus rating of “Buy” by the seven ratings firms that are presently covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have issued a report […]
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are covering the stock, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have covered the stock in the last year […]